News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,220 Results
Type
Article (44141)
Company Profile (312)
Press Release (684767)
Multimedia
Podcasts (77)
Webinars (14)
Section
Business (212088)
Career Advice (2127)
Deals (36438)
Drug Delivery (100)
Drug Development (82340)
Employer Resources (178)
FDA (16752)
Job Trends (15372)
News (356518)
Policy (33455)
Tag
Academia (2713)
Accelerated approval (5)
Adcomms (20)
Allergies (90)
Alliances (52550)
ALS (97)
Alzheimer's disease (1410)
Antibody-drug conjugate (ADC) (143)
Approvals (16745)
Artificial intelligence (294)
Autoimmune disease (23)
Automation (17)
Bankruptcy (365)
Best Places to Work (11964)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (221)
Bladder cancer (81)
Brain cancer (27)
Breast cancer (294)
Cancer (2347)
Cardiovascular disease (182)
Career advice (1784)
Career pathing (32)
CAR-T (163)
Cell therapy (452)
Cervical cancer (20)
Clinical research (66902)
Collaboration (902)
Company closure (2)
Compensation (573)
Complete response letters (19)
COVID-19 (2680)
CRISPR (47)
C-suite (262)
Cystic fibrosis (105)
Data (2344)
Decentralized trials (2)
Denatured (31)
Depression (46)
Diabetes (277)
Diagnostics (6651)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (105)
Drug shortages (27)
Duchenne muscular dystrophy (97)
Earnings (88661)
Editorial (40)
Employer branding (22)
Employer resources (153)
Events (117437)
Executive appointments (768)
FDA (18151)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (800)
Gene editing (119)
Generative AI (26)
Gene therapy (331)
GLP-1 (737)
Government (4535)
Grass and pollen (5)
Guidances (156)
Healthcare (19580)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (124)
Indications (30)
Infectious disease (2829)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (54)
Intellectual property (102)
Interviews (331)
IPO (16868)
IRA (41)
Job creations (3830)
Job search strategy (1516)
Kidney cancer (10)
Labor market (43)
Layoffs (493)
Leadership (19)
Legal (8134)
Liver cancer (78)
Lung cancer (328)
Lymphoma (159)
Machine learning (9)
Management (63)
Manufacturing (334)
MASH (77)
Medical device (14127)
Medtech (14132)
Mergers & acquisitions (20150)
Metabolic disorders (716)
Multiple sclerosis (84)
NASH (16)
Neurodegenerative disease (98)
Neuropsychiatric disorders (27)
Neuroscience (1973)
NextGen: Class of 2025 (6862)
Non-profit (4632)
Now hiring (40)
Obesity (374)
Opinion (222)
Ovarian cancer (80)
Pain (93)
Pancreatic cancer (89)
Parkinson's disease (152)
Partnered (21)
Patents (251)
Patient recruitment (116)
Peanut (49)
People (59660)
Pharmaceutical (69)
Pharmacy benefit managers (19)
Phase I (20992)
Phase II (29446)
Phase III (21844)
Pipeline (1364)
Policy (150)
Postmarket research (2584)
Preclinical (9015)
Press Release (71)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (266)
Rare diseases (391)
Real estate (6240)
Recruiting (66)
Regulatory (22933)
Reports (47)
Research institute (2464)
Resumes & cover letters (363)
Rett syndrome (6)
RNA editing (5)
RSV (44)
Schizophrenia (72)
Series A (138)
Series B (89)
Service/supplier (15)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3849)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (48)
The Weekly (44)
Vaccines (732)
Venture capitalists (43)
Weight loss (243)
Women's health (37)
Worklife (17)
Date
Today (61)
Last 7 days (983)
Last 30 days (3072)
Last 365 days (33276)
2025 (12044)
2024 (36260)
2023 (41161)
2022 (52428)
2021 (57032)
2020 (55661)
2019 (48516)
2018 (36502)
2017 (33570)
2016 (33179)
2015 (39385)
2014 (32958)
2013 (28005)
2012 (30258)
2011 (30871)
2010 (28823)
Location
Africa (761)
Alabama (55)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (40586)
Australia (6752)
California (6511)
Canada (2076)
China (550)
Colorado (278)
Connecticut (289)
Delaware (165)
Europe (88949)
Florida (960)
Georgia (224)
Idaho (60)
Illinois (570)
India (26)
Indiana (328)
Iowa (11)
Japan (174)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (933)
Massachusetts (4891)
Michigan (246)
Minnesota (414)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (68)
New Hampshire (69)
New Jersey (1823)
New Mexico (28)
New York (1830)
North Carolina (1039)
North Dakota (9)
Northern California (2849)
Ohio (214)
Oklahoma (15)
Oregon (37)
Pennsylvania (1440)
Puerto Rico (14)
Rhode Island (34)
South America (1159)
South Carolina (25)
South Dakota (1)
Southern California (2448)
Tennessee (108)
Texas (961)
United States (24530)
Utah (195)
Virginia (155)
Washington D.C. (65)
Washington State (581)
West Virginia (3)
Wisconsin (59)
729,220 Results for "align technology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial
April 1, 2025
·
3 min read
Press Releases
Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease
February 27, 2025
·
6 min read
Press Releases
Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
April 9, 2025
·
8 min read
Business
Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company’s Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026
Align Technology, Inc. today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately.
May 22, 2024
·
5 min read
Press Releases
SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy
April 2, 2025
·
4 min read
BioMidwest
Align Technology Announces $100 Million Open Market Repurchase
Align Technology, Inc. announced that it is planning to repurchase $100 million of Align’s common stock through open market repurchases under Align’s $1.0 billion stock repurchase program that was approved by Align’s Board of Directors in January 2023.
November 6, 2023
·
4 min read
Business
Align Technology Announces Fourth Quarter and Fiscal 2023 Financial Results
Align Technology, Inc., a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, reported financial results for the fourth quarter and year ended December 31, 2023.
January 31, 2024
·
35 min read
Press Releases
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA’s Shift to Non-Animal Testing Methods
April 11, 2025
·
4 min read
BioMidwest
Align Technology Introduces New SmartForce™ Attachment-free Aligner Activation Feature
Align Technology, Inc. introduced a new SmartForce feature, attachment-free aligner activation, that helps minimize the number of attachments while maintaining predictable treatment outcomes.
September 6, 2023
·
5 min read
Genetown
Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
Checkpoint Therapeutics, Inc. today announced it has reached alignment with the Food and Drug Administration (“FDA”) on its biologics license application (“BLA”) resubmission strategy for cosibelimab.
June 24, 2024
·
5 min read
1 of 72,922
Next
